Publication | Closed Access

Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice

NanoparticlesNanomedicineDrug TargetingEngineeringTherapeutic NanomaterialsMedicineVascular BiologyNano-drug DeliveryBiomedical EngineeringPharmacologyAtherosclerosis